Physician profile
John G Vachtsevanos
NPI 1306820832
$7,347.18
in general payments reported to CMS, 2019-2025
16 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,700 · 2020: $175 · 2021: $109 · 2022: $1,041 · 2023: $88.66 · 2024: $101 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corin USA | $5,250.00 | 2019 | |
| Omnilife Science, INC | $954.49 | 2022-2024 | Various Products, Omnibotics 3.0 |
| Pacira Therapeutics, INC. | $316.71 | 2019-2021 | |
| Fx Shoulder Solutions, INC | $197.04 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $171.61 | 2022-2025 | Caldolor |
| Smith+Nephew, INC. | $109.86 | 2019-2023 | Grafix, Stravix |
| Radius Health, INC. | $64.76 | 2021-2022 | |
| Heron Therapeutics, INC. | $60.09 | 2024-2025 | Zynrelef |
| Horizon Therapeutics Plc | $56.97 | 2019-2020 | |
| Ethicon US, LLC | $37.01 | 2020-2022 | |
| Ossdsign USA Incorporated | $29.95 | 2025 | Ossdsign Catalyst |
| Kci USA, INC. | $27.91 | 2019 | |
| Davol INC. | $21.98 | 2025 | |
| Avanos Medical | $20.88 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $14.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vachtsevanos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.